Bioventus director granted RSUs, exercises awards

Bioventus Inc. director Philip G. Cowdy reported equity compensation changes.

Rhea-AI Filing Summary

Bioventus Inc. director Philip G. Cowdy reported equity compensation changes. He received a grant of 25,146 restricted stock units (RSUs), each representing one share of Class A common stock, which will vest based on continued board service. A separate RSU award for 32,282 units vested and was exercised into 32,282 shares of Class A common stock, leaving him with 43,982 common shares directly held and 25,146 RSUs outstanding. These transactions reflect compensation awards and option-like exercises rather than open-market buying or selling.

Insider Trade Summary

32,282 shares exercised/converted

Exercise 3 txns

Insider Cowdy Philip G.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	25,146	$0.00	$0.00
Exercise	Restricted Stock Units	32,282	$0.00	$0.00
Exercise	Class A Common Stock	32,282	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 25,146 contracts (Direct); Class A Common Stock — 43,982 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
2. F2. The RSUs vested on June 2, 2026.
3. F3. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Key Figures

New RSU grant: 25,146 RSUs RSUs exercised: 32,282 RSUs Common shares held: 43,982 shares +1 more

4 metrics

New RSU grant 25,146 RSUs Grant to director Philip G. Cowdy, each for one Class A share

RSUs exercised 32,282 RSUs Vested and converted into Class A common stock on June 2, 2026

Common shares held 43,982 shares Class A common stock directly held after transactions

RSUs outstanding after grant 25,146 RSUs Total restricted stock units following new award

Key Terms

Restricted Stock Units, Class A Common Stock, vested, derivative security

4 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"one share of Class A common stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vested financial

"The RSUs vested on June 2, 2026."

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Bioventus (BVS) director Philip G. Cowdy report?

Philip G. Cowdy reported a new grant of 25,146 restricted stock units and the vesting and exercise of 32,282 RSUs into Class A common stock. These are compensation-related awards, not open-market purchases or sales, and increase his direct share ownership.

How many Bioventus (BVS) shares does Philip G. Cowdy hold after these Form 4 transactions?

After these transactions, Philip G. Cowdy directly holds 43,982 shares of Bioventus Class A common stock. He also has 25,146 restricted stock units outstanding, each representing a contingent right to receive one additional share upon future vesting conditions being satisfied.

What restricted stock unit grants did Bioventus (BVS) report for Philip G. Cowdy?

Bioventus reported a grant of 25,146 restricted stock units to director Philip G. Cowdy. Each RSU represents a contingent right to receive one share of Class A common stock, subject to future vesting based on continued service on the company’s board of directors.

When did Philip G. Cowdy’s Bioventus (BVS) RSUs vest and convert to shares?

A previously granted RSU award for 32,282 units vested on June 2, 2026 and was exercised into 32,282 shares of Bioventus Class A common stock. The vesting followed the terms of the award agreement described for the company’s director compensation.

Are the Bioventus (BVS) transactions by Philip G. Cowdy open-market trades?

The reported transactions are not open-market trades. They consist of a grant of 25,146 restricted stock units and the vesting and exercise of 32,282 RSUs into Class A common stock as part of equity compensation, with no reported open-market buying or selling activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 04:46 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cowdy Philip G.

(Last) (First) (Middle)

4721 EMPEROR BOULEVARD, SUITE 100

(Street)

DURHAM NORTH CAROLINA 27703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bioventus Inc. [ BVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/02/2026		M		32,282	A	$0	43,982	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/02/2026		M			32,282	(2)	(2)	Class A Common Stock	32,282	$0	0	D
Restricted Stock Units	(1)	06/03/2026		A		25,146		(3)	(3)	Class A Common Stock	25,146	$0	25,146	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. The RSUs vested on June 2, 2026.

3. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Remarks:

	/s/ Anthony D'Adamio, Attorney-in-Fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)